RecruitingNot ApplicableNCT07288970

ACB With S-ESPB Versus ACB With iPACK for Knee Arthroplasty

Comparison of Adductor Canal Block Combined With Sacral Erector Spinae Plane Block Versus Adductor Canal Block Combined With iPACK Block in Patients Undergoing Total Knee Arthroplasty: A Randomized Controlled Tria


Sponsor

Poznan University of Medical Sciences

Enrollment

80 participants

Start Date

Dec 25, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study will compare two regional anesthesia strategies for pain management after total knee arthroplasty in adults. Both strategies use an adductor canal block (ACB) to provide analgesia while preserving quadriceps muscle strength. The ACB is then combined with either a sacral erector spinae plane block (S-ESPB) or an iPACK (infiltration between the popliteal artery and the posterior capsule of the knee) block to improve posterior knee analgesia. All patients will receive an ultrasound-guided adductor canal block with 20 mL of 0.2% ropivacaine. They will then be randomly assigned to one of two groups: Group 1: ACB combined with a sacral erector spinae plane block (S-ESPB) using 20 mL of 0.2% ropivacaine. Group 2: ACB combined with an iPACK block using 20 mL of 0.2% ropivacaine. Both techniques aim to provide effective postoperative analgesia while minimizing motor blockade and allowing for early mobilization. It is not known whether combining ACB with S-ESPB or with iPACK provides superior pain control, reduces opioid requirements, or results in better functional recovery after total knee arthroplasty. The main purpose of this study is to compare the time to first rescue analgesia and overall postoperative pain control between the two regional anesthesia strategies. The study will also evaluate opioid consumption, motor function, functional mobility, side effects, and block-related complications. We hypothesize that both combinations will provide effective analgesia, but their impact on pain intensity, duration of analgesia, and functional recovery may differ.


Eligibility

Min Age: 65 YearsMax Age: 100 Years

Inclusion Criteria6

  • Age 65 years or older
  • Scheduled for elective unilateral total knee arthroplasty under spinal or general anesthesia
  • ASA physical status I-III
  • Planned use of regional anesthesia with an adductor canal block as part of multimodal analgesia
  • Ability to communicate pain intensity using the NRS scale
  • Written informed consent obtained from the patient

Exclusion Criteria11

  • Refusal or inability to provide informed consent
  • Allergy, intolerance, or contraindication to local anesthetics (ropivacaine)
  • Pre-existing significant neurological deficit or neuropathy in the operative limb
  • Coagulopathy or anticoagulation that contraindicates peripheral nerve blocks (e.g., INR >1.5, platelets <100,000/µL, or therapeutic anticoagulation that cannot be safely paused)
  • Infection at or near the planned needle insertion sites
  • Severe hepatic or renal impairment
  • Chronic opioid therapy (>30 days of daily opioid use before surgery)
  • Cognitive impairment or delirium preventing reliable pain assessment BMI > 40 kg/m² (optional - if chcesz ograniczyć ze względu na trudność USG)
  • Previous knee arthroplasty on the same side or revision TKA (jeśli chcesz tylko primary TKA)
  • Pregnancy or breastfeeding
  • Participation in another interventional clinical trial within 30 days

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAdductor Canal Block

Ultrasound-guided adductor canal block performed with 20 mL of 0.2% ropivacaine injected around the saphenous nerve within the adductor canal. Used in both study arms as part of the regional anesthesia protocol for total knee arthroplasty.

PROCEDURESacral Erector Spinae Plane Block

Ultrasound-guided sacral erector spinae plane block performed with 20 mL of 0.2% ropivacaine injected deep to the erector spinae muscle at the sacral level. Used in combination with ACB in the ACB + S-ESPB group.

PROCEDUREiPACK Block

Ultrasound-guided iPACK block performed with 20 mL of 0.2% ropivacaine injected between the popliteal artery and the posterior capsule of the knee. Used in combination with ACB in the ACB + iPACK group.


Locations(1)

Poznan University of Medical Sciences

Poznan, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07288970


Related Trials